{"id":"W2786821373","doi":"10.1007/s11938-018-0175-1","title":"Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease","year":2018,"lang":"en","type":"review","venue":"Current Treatment Options in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Janssen Biotech; Allergan; Baxter Healthcare Corporation; Genentech; Gilead Sciences; Ablynx; Biogen; Celgene; Novo Nordisk; Teva Pharmaceutical Industries; ActoGeniX; Sanofi; Amgen; Pfizer; Ironwood Pharmaceuticals, Incorporated; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Vedolizumab; Natalizumab; Inflammatory bowel disease; Drug; Clinical trial; Disease; Pharmacology; Immunology; Intensive care medicine; Internal medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006357217,0.0007607628,0.0007018728,0.0002289689,0.0001302818,0.00005893103,0.0001822298,0.000184288,0.000007780292],"category_scores_gemma":[0.00001252368,0.0005423766,0.0003392864,0.00004370817,0.0003530183,0.00001639505,0.00007800733,0.00007719237,0.000006537981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002565133,"about_ca_system_score_gemma":0.0004282627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001936362,"about_ca_topic_score_gemma":0.0002183711,"domain_scores_codex":[0.9978323,0.0001596743,0.0005041853,0.0008744303,0.00009875625,0.0005306346],"domain_scores_gemma":[0.9987645,0.00002578957,0.0002839495,0.000606005,0.0001021575,0.0002175819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01166593,0.01955233,0.4568639,0.01266748,0.006327797,0.0001022942,0.0005356678,0.000165044,0.000009164017,0.00128848,0.0006657934,0.4901562],"study_design_scores_gemma":[0.01123835,0.007420062,0.07515271,0.002024382,0.002152202,0.00001520716,0.00005963542,0.0000234751,2.881107e-7,0.00004423402,0.9011367,0.0007327414],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1740213,0.8192825,0.0004259904,0.00001366159,0.0004319888,0.003850735,0.001932116,0.00003263271,0.000009147688],"genre_scores_gemma":[0.002694863,0.9875599,0.0005501393,0.00001353085,0.0003026736,0.004421295,0.004317637,0.0000895747,0.00005036052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9004709,"threshold_uncertainty_score":0.9997028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02647416217574117,"score_gpt":0.3008999525957434,"score_spread":0.2744257904200023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}